Acute Porphyria Drug Database

N06AB03 - Fluoxetine
Not porphyrinogenic
NP

Rationale
Fluoxetine is a MI complexing agent in rat liver, but not necessarily in human liver. Not porphyrinogenic in chick hepatocyte culture. Repeated clinical experience points to non-porphyrinogenicity. Several references consider it safe.
Chemical description
(To be edited, initial data ST OCT 04) Serotonine reuptake inhibitor. Strong CYP 2D6- and CYP 3A4 -inhibitor of long duration. Australian list: safe EPI-list: safe South African list: use with care French list: use Thunell; patient inquiry; clinical observation: tolerated (n=7) H.Bonkovsky:
IPNet drug reports
Uneventful use reported in 41 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes N06A / N06AB or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙